Excited about our recent publication on Armored TGFBRIIdn ROR1-targeting CAR T cells for solid tumors - Dina Schneider
Journal for ImmunoTherapy of Cancer
#CARTCells #Cancer #CellTherapy #ImmunoOncology #Immunosuppression #OncoDaily #Oncology #SolidTumors
oncodaily.com/51934.html
Unveiling the hidden layers of sex bias in immuno-oncology! Discover how biological sex influences cancer outcomes & treatment responses by diving into perspectives by Zihai Li, MD, PhD and Justin Lathia, PhD 🧠🕺🏽 labs in this Nature Reviews Cancer article
#SexBias #ImmunoOncology
go.osu.edu/Cps8
Providing Hope For Animals With Cancer - Ashley Kalinauskas - Ashley Kalinauskas - Founder & CEO, Torigen Pharmaceuticals Progress, Potential, And Possibilities UConn UConnResearch University of Notre Dame #CancerVaccines #AnimalHealth #TumorAntigens #ExtracellularMatrix #Veterinary #Veterinarians #ImmunoOncology
I have been selected as a Pelotonia Scholar via the The Pelotonia Scholars Program at the The James - Jay Mandula
#Cancer #Cancer Research #Cancer Survivors #ImmunoOncology #OncoDaily #Oncology #Pelotonia2024
oncodaily.com/48933.html
In this Genetic Engineering & Biotechnology News article, JAX offers several key tips compiled for maximizing the effectiveness of Onco-Hu™ mice in #immunooncology drug efficacy studies: bit.ly/49tahLJ
Join us at the #IOTNCapstoneMeeting on May 14 – 15 to learn about scientific accomplishments in #ImmunoOncology across the IOTN Moonshot network. Additional information and registration can be found at events.cancer.gov/dcb/iotncapsto…. #CancerMoonshot
Join us at the #IOTNCapstoneMeeting on May 14 – 15 to learn about scientific accomplishments in #ImmunoOncology across the IOTN Moonshot network. Additional information and registration can be found at events.cancer.gov/dcb/iotncapsto…. #CancerMoonshot
🔬 In an exclusive interview with #ONCOLife , Dr. Johan Baeck, unveils insights into #PT112 , a pioneering #cancer therapy. This innovative treatment targets #ribosomal biogenesis, representing a significant shift in the landscape of #immunooncology .
healthandpharma.net/johan-baeck-pa…
The 8th Immuno-Oncology Summit Europe will be held in London, England on April 23-25, 2024 - please check the link for more details ow.ly/IcqF50RjHsH Cambridge Healthtech Institute #ImmunoOncology #Immunotherapy
Out team is attending Immuno 2024. They look forward to connecting with you at the event so please don't hesitate to reach out and ask them about our Immuno-Oncology in vivo and in vitro capabilities
#Immuno2024 #drugdiscovery #immunooncology #syngeneic
On May 2 at 12:00 pm ET, Dr. Sarah Mullin Roswell Park will discuss real-time #ArtificialIntelligence monitoring & the early detection of immune-related adverse events ( #irAEs ) during an National Cancer Institute & Society for Immunotherapy of Cancer computational #ImmunoOncology webinar: sitcancer.org/education/webi…
Excited to share our paper on Precision Immuno-Oncology in NSCLC through Gender Equity Lenses - #FlorezLab
Jennifer Marks, MD Arthi Sridhar MDPI
#Cancer #NSCLC #OncoDaily #Oncology #PrecisionMedicine #ImmunoOncology #GenderEquity
oncodaily.com/47484.html
Providing Hope For Animals With Cancer - #AshleyKalinauskas - Founder & CEO, #Torigen Inc., #ProgressPotentialAndPossibilities #UConn #NotreDame #CancerVaccines #AnimalHealth #TumorAntigens #ExtracellularMatrix #Veterinary #Veterinarians #ImmunoOncology #Autologous
Early-bird registration savings of up to $600 ends this Friday, April 19 for #IOSummit ! View the final agenda and reserve your spot today to lock in early-bird rates at tinyurl.com/5fptn5zj
#Immunotherapy #ImmunoOncology
Horizon scanning in oncology. Researching therapies, reducing adverse effects and toxicities with improved patient outcomes. CAR-T in glioblastoma. Small study but interesting. #CAR #TCell #oncology #horizonscanning #NurseEducation #immunotherapy #immunooncology
Awesome by John now at Duke on how T cells remodeling #TME #immunooncology #multiplexedimaging
On May 2 at 12:00 pm ET, Dr. Sarah Mullin Roswell Park will discuss real-time #ArtificialIntelligence monitoring & the early detection of immune-related adverse events ( #irAEs ) during an National Cancer Institute & Society for Immunotherapy of Cancer computational #ImmunoOncology webinar: sitcancer.org/education/webi…
On May 2 at 12:00 pm ET, Dr. Sarah Mullin Roswell Park will discuss real-time #ArtificialIntelligence monitoring & the early detection of immune-related adverse events ( #irAEs ) during an National Cancer Institute & Society for Immunotherapy of Cancer computational #ImmunoOncology webinar: sitcancer.org/education/webi…
